Details on the FDA new draft Guidance, "Content of Human Factors Information in Medical Device Marketing Submissions."

On December 9th the FDA released a new draft Guidance, Content of Human Factors Information in Medical Device Marketing Submissions. The draft guidance can be accessed here: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/content-human-factors-information-medical-device-marketing-submissions

The new guidance takes a risk-based approach to determining the required amount of HF Data for a submission. In some instances, this will reduce the amount of HF Data required for modified devices.

Summary of Key Points:

  • After finalization, this guidance will supersede the draft guidance “List of Highest Priority Devices of Human Factors Review.”

  • Upon finalization of the new draft guidance, FDA intends to concurrently revise “Applying Human Factors and Usability Engineering to Medical Devices” to:

o   incorporate the definitions from the new guidance

o   replace Section 9 “Documentation”

o   replace Appendix A “Human Factors and Usability Engineering Report”

  • The requirements for the HF Data to include in the submission are based on the HF Submission Category. The new guidance provides three Human Factors (HF) Submission Categories:

o   Submission Category 1: Modified devices in which there are NO changes to the UI, intended users, intended uses, intended use environments, training and labelling.

o   Submission Category 2: New devices with no critical tasks or modified devices in which there were changes to one or more of the following: UI, intended users, intended uses, intended use environments, training and labelling but there are NO new critical tasks introduced and/or NO change that impacts critical tasks.

o   Submission Category 3: New devices with critical tasks or modified devices with new critical tasks introduced or existing critical tasks impacted by changes.

  • The new guidance provides the following table:

Agilis